Uti Infection Control Tablet
NDC Package 73436-1221-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Uti Infection Control (methenamine, sodium salicylate) tablets is adults and children 12 years and over:take 2 tablets with a full glass of water 3 times a day. This formulation utilizes a tablet delivery system. Marketed by Cadence Health, Inc., this product is identified by NDC 73436-1221.

Identification & Billing

NDC Package Code
73436-1221-2
Package Description
1 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK
Product Code
73436-1221
11-Digit Billing Format
73436122102
RxNorm Crosswalk
RxCUI: 1489932 - methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Uti Infection Control
Non-Proprietary Name
Methenamine, Sodium Salicylate
Substance Name
Methenamine; Sodium Salicylate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Adults and children 12 years and over:take 2 tablets with a full glass of water 3 times a day. Drink plenty of fluids.Do not use for more than a 3 day period unless directed by a doctor.Children under 12 years:ask a doctor.

Regulatory & Marketing

Labeler Name
Cadence Health, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
04-06-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73436-1221-2 identifies a specific commercial package of 1 blister pack in 1 carton / 12 tablet in 1 blister pack of Uti Infection Control, a human over the counter drug labeled by Cadence Health, Inc.. This tablet is formulated for oral use and contains methenamine; sodium salicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cadence Health, Inc. on April 06, 2026. The current certification is valid through December 31, 2027.

How is this Cadence Health, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73436122102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
73436-1221-2
11-Digit CMS (5-4-2)
73436-1221-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.